# Single Ascending and Multiple Ascending Dose Study of LCA-0061

> **NCT07701954** · PHASE1 · RECRUITING · sponsor: **Lycia Therapeutics, Inc.** · enrollment: 72 (estimated)

## Conditions studied

- Atopic Disease
- Peanut Allergies

## Interventions

- **DRUG:** LCA-0061
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07701954
- **Lead sponsor:** Lycia Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-26
- **Primary completion:** 2028-04
- **Final completion:** 2028-04
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07701954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07701954, "Single Ascending and Multiple Ascending Dose Study of LCA-0061". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07701954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*